cycloplatam

05/01/1996 - "[Cycloplatam in the treatment of patients with disseminated prostatic cancer]."
05/01/1996 - "In 80% of cases the drug has improved quality of life of patients with prostatic cancer stage III and IV. Antitumor effect and low toxicity make cycloplatam applicable in combined therapy of prostatic cancer."
05/01/1996 - "A 22% response rate was achieved in clinical trials of Russian drug cycloplatam in disseminated and hormone-resistant cancer of the prostate. "

01/01/1990 - "[Cycloplatin (LACHEMA) in ovarian carcinoma. "
03/01/2006 - "Cycloplatam has been shown to be effective in the treatment of pleural mesothelioma, myeloma and ovarian carcinoma. "
01/01/2001 - "They include treatment of solid tumors with cycloplatam alone in urinary bladder tumors, cervical carcinoma and malignant pleurites of various etiology as well as in combination with other cytostatics (carcinoma of the prostate, pleural mesothelioma and urinary bladder tumors). "

03/01/2006 - "Cycloplatam has been shown to be effective in the treatment of pleural mesothelioma, myeloma and ovarian carcinoma. "
01/01/2001 - "They include treatment of solid tumors with cycloplatam alone in urinary bladder tumors, cervical carcinoma and malignant pleurites of various etiology as well as in combination with other cytostatics (carcinoma of the prostate, pleural mesothelioma and urinary bladder tumors). "

10/01/2016 - "By contrast, liposomal cycloplatam had lower efficiency than free cycloplatam in suppressing the growth of solid tumor. "
01/01/2001 - "[Results of phase II clinical trial of cycloplatam in refractory solid tumors]."
08/01/2014 - "The observed changes can be stipulated by different effects of cyclophosphamide and cycloplatam on the subpopulations of lymphoid cells taking part in the formation of antitumor immunity and resistance to tumors."
03/01/2006 - "Cycloplatam is not nephrotoxic with respect to the platinum-based anti-tumor agents. "
01/01/1989 - "[Effectiveness of cycloplatam in the free form and included in liposomes during metastasis of GA-1 tumors in A/He mice]."

10/01/2016 - "Hydrophilic drug cycloplatam (injected intravenously in liposomes) was more potent than "free cycloplatam" (injected intravenously or intraperitoneally in physiological saline) in inhibiting the growth of natural and experimental metastases in the liver. "
01/01/1989 - "When injected intravenously to mice with HA-1 tumour metastases in the liver, liposome-encapsulated cycloplatam increased their survival rate by 112-123%, whereas free cycloplatam--only by 39-61% as compared to the control. "
01/01/1989 - "[Effectiveness of cycloplatam in the free form and included in liposomes during metastasis of GA-1 tumors in A/He mice]."